Home › Funds › Campbell & CO Investment Adviser LLC › WST

Campbell & CO Investment Adviser LLC position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Campbell & CO Investment Adviser LLC reported holding 26,633 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$9.9M, representing 0.42% of its reported portfolio and ranking #31 among its reported holdings. Campbell & CO Investment Adviser LLC has disclosed WST holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)26.63K sh
Reported value held$9.87M
Portfolio Weight0.42%
First reportedQ3 2023
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Campbell & CO Investment Adviser LLC's WST position evolved

Campbell & CO Investment Adviser LLC first disclosed a stake in WST in Q3 2023 at 3,746 shares (US$1.4M). The position peaked in Q3 2026 at 26,633 shares, worth US$9.9M. Across 6 filings, Campbell & CO Investment Adviser LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 26,633 shares valued at US$9.9M. Notable position changes include a 46% trim in Q1 2024 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.75K $1.41M New
Q4 2023 3.30K $1.16M Reduce
Q1 2024 1.78K $706.34K Reduce
Q3 2024 904 $271.35K New
Q4 2025 18.60K $5.12M New
Q3 2026 26.63K $9.87M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Campbell & CO Investment Adviser LLC held WST?

Campbell & CO Investment Adviser LLC has disclosed WST holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

What is Campbell & CO Investment Adviser LLC's current position in WST?

As of Q3 2026, Campbell & CO Investment Adviser LLC holds 26.63K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $9.87M, representing 0.42% of its reported portfolio and ranking #31.

Has Campbell & CO Investment Adviser LLC been buying or selling WST?

In the latest 13F filing (Q3 2026), Campbell & CO Investment Adviser LLC newly opened its position in WST. The position peaked in Q3 2026 at 26.63K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.